Skip to main content

Table 12 Difference in means between treatment and control groups for SBP at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author Sample size (treatment group vs. control group) Difference 95% CI
Liu et al. [64] 119 (60 vs. 59) − 1.00 mmHg** − 3.87 to 1.87
Mainenti et al. [65] 23 (11 vs. 12) − 12.25 mmHg* − 29.53 to 5.03
Monzani et al. [67] 20 (10 vs. 10) 0.50 mmHg* − 6.79 to 7.79
Monzani et al. [68] 45 (23 vs. 22) − 2.00 mmHg* − 10.19 to 6.19
Nagasaki et al. [69] 95 (48 vs. 47) − 3.40 mmHg** − 10.56 to 3.76
Stott et al. [73] 638 (318 vs. 320) − 0.1 mmHg* − 2.1 to 2.4
Yazici et al. [76] 45 (23 vs. 22) 0.50 mmHg* − 5.23 to 6.23
Zhao et al. [77] 369 (210 vs. 159) − 2.54 mmHg* − 6.65 to 1.57
  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group